(Q39457280)

12 September 2017

Therapy of advanced squamous carcinoma of the lung: cyclophosphamide vesus "COMB". (English)

1 reference

12 September 2017

Therapy of advanced squamous carcinoma of the lung.Cyclophosphamide versus “COMB” (English)

1 reference

10.1002/1097-0142(197703)39:3<1026::AID-CNCR2820390305>3.0.CO;2-P

https://api.crossref.org/works/10.1002/1097-0142(197703)39:3%3C1026::AID-CNCR2820390305%3E3.0.CO;2-P

14 April 2022

Therapy of advanced squamous carcinoma of the lung: cyclophosphamide vesus "COMB" (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A71943

14 April 2022

1 reference

10.1002/1097-0142(197703)39:3<1026::AID-CNCR2820390305>3.0.CO;2-P

https://api.crossref.org/works/10.1002/1097-0142(197703)39:3%3C1026::AID-CNCR2820390305%3E3.0.CO;2-P

14 April 2022

author name string

Bodey GP

1

1 reference

12 September 2017

Lagakos SW

2

1 reference

12 September 2017

Gutierrez AC

3

1 reference

12 September 2017

Wilson HE

4

1 reference

12 September 2017

Selawry OS

5

1 reference

12 September 2017

G. P. Bodey

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A71943

14 April 2022

S. W. Lagakos

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A71943

14 April 2022

A. C. Gutierrez

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A71943

14 April 2022

H. E. Wilson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A71943

14 April 2022

O. S. Selawry

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A71943

14 April 2022

language of work or name

English

0 references

publication date

1 March 1977

1 reference

full work available at URL

12 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197703)39:3%3C1026::AID-CNCR2820390305%3E3.0.CO;2-P

1 reference

10.1002/1097-0142(197703)39:3<1026::AID-CNCR2820390305>3.0.CO;2-P

https://api.crossref.org/works/10.1002/1097-0142(197703)39:3%3C1026::AID-CNCR2820390305%3E3.0.CO;2-P

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197703)39:3%3C1026::AID-CNCR2820390305%3E3.0.CO;2-P

14 April 2022

1 reference

10.1002/1097-0142(197703)39:3<1026::AID-CNCR2820390305>3.0.CO;2-P

https://api.crossref.org/works/10.1002/1097-0142(197703)39:3%3C1026::AID-CNCR2820390305%3E3.0.CO;2-P

14 April 2022

1 reference

12 September 2017

39

1 reference

12 September 2017

1026-1031

1 reference

12 September 2017

3

1 reference

12 September 2017

1

31

1218

Barranco

1971

1 reference

10.1002/1097-0142(197703)39:3<1026::AID-CNCR2820390305>3.0.CO;2-P

https://api.crossref.org/works/10.1002/1097-0142(197703)39:3%3C1026::AID-CNCR2820390305%3E3.0.CO;2-P

A clinical review of bleomycin--a new antineoplastic agent

14 April 2022

2

31

903

Blum

1973

1 reference

10.1002/1097-0142(197703)39:3<1026::AID-CNCR2820390305>3.0.CO;2-P

https://api.crossref.org/works/10.1002/1097-0142(197703)39:3%3C1026::AID-CNCR2820390305%3E3.0.CO;2-P

14 April 2022

Biochemical Pharmacology

4

2

177

Bodey

1974

1 reference

10.1002/1097-0142(197703)39:3<1026::AID-CNCR2820390305>3.0.CO;2-P

https://api.crossref.org/works/10.1002/1097-0142(197703)39:3%3C1026::AID-CNCR2820390305%3E3.0.CO;2-P

Lung cancer: perspectives and prospects

14 April 2022

5

73

1003

Carbone

1970

1 reference

10.1002/1097-0142(197703)39:3<1026::AID-CNCR2820390305>3.0.CO;2-P

https://api.crossref.org/works/10.1002/1097-0142(197703)39:3%3C1026::AID-CNCR2820390305%3E3.0.CO;2-P

14 April 2022

6

24

1918

Frei

1964

1 reference

10.1002/1097-0142(197703)39:3<1026::AID-CNCR2820390305>3.0.CO;2-P

https://api.crossref.org/works/10.1002/1097-0142(197703)39:3%3C1026::AID-CNCR2820390305%3E3.0.CO;2-P

A comparison of nitrogen mustard, vincristine, procarbazine, and prednisone (mopp) vs. nitrogen mustard in advanced hodgkin's disease

14 April 2022

7

36

1227

Huguley

1975

1 reference

10.1002/1097-0142(197703)39:3<1026::AID-CNCR2820390305>3.0.CO;2-P

https://api.crossref.org/works/10.1002/1097-0142(197703)39:3%3C1026::AID-CNCR2820390305%3E3.0.CO;2-P

COMB (cyclophosphamide, oncovin, methyl-CCNU, and bleomycin): a four-drug combination in solid tumors

14 April 2022

9

36

327

Livingston

1975

1 reference

10.1002/1097-0142(197703)39:3<1026::AID-CNCR2820390305>3.0.CO;2-P

https://api.crossref.org/works/10.1002/1097-0142(197703)39:3%3C1026::AID-CNCR2820390305%3E3.0.CO;2-P

Clinical comparison of the nitrosoureas

14 April 2022

13

volume

36

0 references

Identifiers

10.1002/1097-0142(197703)39:3<1026::AID-CNCR2820390305>3.0.CO;2-P

1 reference

12 September 2017

1 reference